AmerisourceBergen (ABC) Completes Canadian Pharma Distribution Divestiture; Sees Adjustments
Tweet
Share
E-mailGet Alerts ABC Hot Sheet
Join SI Premium – FREE
AmerisourceBergen Corporation (NYSE: ABC) has completed the divestiture of its Canadian pharmaceutical distribution business, AmerisourceBergen Canada Corporation (ABCC). As previously announced, the business has been sold to Kohl & Frisch Limited, a Canadian-owned national full-line distributor. AmerisourceBergen will retain its Canadian specialty business.
In the quarter ended March 31, 2013, the Company recorded an estimated loss on sale and other impairment charges of $161.7 million, which is subject to post closing purchase price adjustments. The Company expects to finalize these adjustments with Kohl & Frisch Limited during the quarter ending September 30, 2013. The results of operations of ABCC, and the loss on sale and impairment charges are reported in discontinued operations.
In the quarter ended March 31, 2013, the Company recorded an estimated loss on sale and other impairment charges of $161.7 million, which is subject to post closing purchase price adjustments. The Company expects to finalize these adjustments with Kohl & Frisch Limited during the quarter ending September 30, 2013. The results of operations of ABCC, and the loss on sale and impairment charges are reported in discontinued operations.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Paramount Skydance clears global regulators for WBD deal, faces state AG suit
- Optimum Communications gets NYSE non-compliance notice over stock price
- Stripe, Advent In Talks To Buy Paypal - WSJ
Create E-mail Alert Related Categories
Corporate News, Guidance, Mergers and AcquisitionsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
